PharmAssess Diagnostics Corp.
PrivateLast Round
Grant
Jan 1, 2021
Total Funding Raised
$8,500
Company Overview
PharmAssess Diagnostics Corp. is a health technology company that provides diagnostic software solutions to assist pharmacists in the assessment, treatment, and documentation of minor ailments.
Sector
Healthcare & Life Sciences
Verticals
Vertical SaaS, Workflow Automation, Patient Engagement
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PharmAssess Diagnostics Corp. Comparables
Compare PharmAssess Diagnostics Corp. with similar companies based on industry and business-model similarity.
PharmAssess Diagnostics Corp. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 1, 2021 | ||||
| Accelerator | Aug 6, 2020 | ||||
| Grant | Mar 1, 2019 |
PharmAssess Diagnostics Corp. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| gener8tor | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 11, 2026
Monthly visitors increased 95% MoM, reaching 6.4K.
- Jan 1, 2021
$4.7K grant round completed.
PharmAssess Diagnostics Corp. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about PharmAssess Diagnostics Corp.'s valuation, stock price, and market status.
Is PharmAssess Diagnostics Corp. a public or private company?
PharmAssess Diagnostics Corp. is a private company.
What is the current stock price of PharmAssess Diagnostics Corp.?
PharmAssess Diagnostics Corp. is a private company, so its shares have no public market price. Caplight tracks PharmAssess Diagnostics Corp.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PharmAssess Diagnostics Corp. worth (valuation)?
Valuation information for PharmAssess Diagnostics Corp. is not publicly available.
Can I buy PharmAssess Diagnostics Corp. stock?
PharmAssess Diagnostics Corp. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PharmAssess Diagnostics Corp.'s last funding round?
PharmAssess Diagnostics Corp.'s most recent funding round was Grant on January 1, 2021.
Who are the main investors in PharmAssess Diagnostics Corp.?
Key investors in PharmAssess Diagnostics Corp. include gener8tor.
Will PharmAssess Diagnostics Corp. IPO soon?
No public IPO plans have been announced for PharmAssess Diagnostics Corp..
How can I track PharmAssess Diagnostics Corp. secondary market activity?
Caplight tracks bids, offers, and trades in PharmAssess Diagnostics Corp.'s shares on secondary markets.